Download Sample
Add to CartGlobal Cbd Oil (Cannabidiol Oil) Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Type;
THC Dominant, CBD Dominant, Marijuana Based, and Hemp BasedBy Formulation;
Pills & Capsule, Creams & Roll-Ons, Transdermel Patches, Drops, and OthersBy Product;
Hemp Oil and Marijuana OilBy Application;
Pharmaceuticals, Food & Beverages - [Gummies, Chewing Gums, Chocolate Bars, Candies, Beverages, Dairy Products, Bakery Products, and Snacks], Cosmetics, and OthersBy Distribution channel;
Direct/B2B, Indirect/B2C, Hospital Pharmacy, Retail Pharmacy, Hypermarkets/Supermarkets, Convenience Store, Online Retail, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Cbd Oil (Cannabidiol Oil) Market Overview
Cbd Oil (Cannabidiol Oil) Market (USD Million)
Cbd Oil (Cannabidiol Oil) Market was valued at USD 17,327.87 million In the year 2024. The size of this market is expected to increase to USD 143,155.08 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 35.2%.
Global Cbd Oil (Cannabidiol Oil) Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 35.2 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 35.2 % |
| Market Size (2024) | USD 17,327.87 Million |
| Market Size (2031) | USD 143,155.08 Million |
| Market Concentration | Low |
| Report Pages | 350 |
Major Players
- CV Sciences
- Medical Marijuana
- Aurora Cannabis
- Canopy Growth Corporation
- Canntrust
- Tilray
- Kazmira LLC
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Cbd Oil (Cannabidiol Oil) Market
Fragmented - Highly competitive market without dominant players
The CBD oil market is experiencing significant growth, fueled by a rising consumer preference for natural health remedies. CBD oil, derived from the hemp plant, is recognized for its potential therapeutic benefits without the psychoactive effects associated with THC. This shift towards holistic health solutions is evident as approximately 64% of Americans are familiar with CBD, leading to increased adoption rates.
Diverse Applications in Health and Wellness
CBD oil's versatility is evident in its wide range of applications, from pain management to mental health support. Notably, 64% of users consume CBD for pain relief, 49% for anxiety relief, and 22% to improve sleep quality. This broad spectrum of uses underscores CBD oil's role in promoting overall well-being and its growing acceptance in the health and wellness sector.
Supportive Regulatory Environment and Mainstream Acceptance
The CBD oil market is also benefiting from a supportive regulatory landscape, which has facilitated broader consumer access and mainstream acceptance. Recent industry reports indicate that a significant percentage of new wellness brands now incorporate CBD as a key ingredient in their product lines, reflecting a notable shift in market dynamics. This regulatory support is expected to enhance product availability and consumer trust, further accelerating market growth.
Robust Growth Trajectory and Market Potential
As scientific research continues to validate the therapeutic potential of CBD oil, the market is poised for sustained growth. Projections indicate that the demand for CBD oil could increase significantly in the coming years, driven by evolving consumer preferences, ongoing product innovation, and expanding distribution channels. This robust growth outlook highlights the market's potential to transform the broader wellness and healthcare industries.
Cbd Oil (Cannabidiol Oil) Market Recent Developments
-
In October 2022, Charlotte's Web Holdings, Inc., a leading producer of full-spectrum hemp-derived CBD products, announced a strategic partnership with Gopuff, a prominent on-demand delivery platform. This collaboration aimed to enhance consumer accessibility to Charlotte's Web's range of CBD offerings, including CBD oil tinctures, topical creams, and balms, across key markets like Arizona, Illinois, California, and New York.
-
In May 2022, Medical Marijuana, Inc. established its first pharmaceutical subsidiary, HM Pharma, in Brazil to enhance the availability of CBD products in pharmacies. Operating under Anvisa Normative 327/2019, this subsidiary aims to provide patients with high-quality, affordable CBD options through regulated pharmacy channels.
Cbd Oil (Cannabidiol Oil) Market Segment Analysis
In this report, the Cbd Oil (Cannabidiol Oil) Market has been segmented by Type, Formulation, Product, Application, Distribution Channel and Geography.
Cbd Oil (Cannabidiol Oil) Market, Segmentation by Type
The Cbd Oil (Cannabidiol Oil) Market has been segmented by Type into THC Dominant, CBD Dominant, Marijuana Based and Hemp Based.
THC Dominant Products
THC dominant CBD oil products serve a niche yet growing market segment, particularly favored in regions with legal recreational cannabis. Representing around 15% of the market, these products appeal to consumers seeking both therapeutic and mild psychoactive effects. Although restricted in many areas, demand is climbing where legislation permits use, especially for chronic conditions like insomnia and persistent pain.
CBD Dominant Products
CBD dominant oils lead the cannabidiol market with a commanding 45% share. Known for being non-psychoactive, these products are highly sought after for treating anxiety, inflammation, and neurological disorders such as epilepsy. Their popularity is fueled by consumer preference for natural health solutions and the growing endorsement from medical professionals and wellness communities.
Marijuana-Based Oils
Making up about 25% of the CBD oil market, marijuana-based products are extracted from cannabis strains that naturally contain higher THC levels. These oils combine both CBD and THC, delivering enhanced therapeutic benefits. Their usage is particularly prominent in the medical cannabis sector, where they are prescribed for serious health conditions including cancer and multiple sclerosis.
Hemp-Based Oils
Hemp-based CBD oils occupy an estimated 30% of the global market. Extracted from industrial hemp, these products contain minimal THC and are legally distributed in a wide range of countries. Widely integrated into dietary supplements and skincare products, hemp-based oils enjoy a robust demand thanks to their legal status, safety profile, and appeal to health-conscious consumers.
Cbd Oil (Cannabidiol Oil) Market, Segmentation by Formulation
The Cbd Oil (Cannabidiol Oil) Market has been segmented by Formulation into Pills and Capsule, Creams and Roll-Ons, Transdermel Patches, Drops, and Other.
Pills and Capsules
CBD pills and capsules offer a practical and consistent way to consume cannabidiol, holding around 30% of the global market share. These formulations are particularly favored by consumers who prioritize dosage precision and ease of use. With applications in both the medical and wellness fields, their demand continues to rise due to their portability and discreet nature.
Creams and Roll-Ons
CBD creams and roll-ons account for nearly 25% of the market. These topicals are designed for targeted application, offering localized relief from pain, inflammation, and skin-related issues. Their non-invasive use and increasing adoption among fitness enthusiasts and older adults contribute significantly to their market growth.
Transdermal Patches
Holding a modest 10% share, transdermal CBD patches provide a unique method of delivering cannabidiol through the skin for extended relief. These patches are ideal for users managing chronic conditions as they release CBD steadily over time. Their effectiveness in providing long-lasting effects is fueling their rising popularity.
Drops and Other Forms
Dominating the category with about 35%, CBD drops and tinctures are widely recognized for their fast absorption and dosing versatility. Ideal for both beginners and regular users, these drops allow sublingual consumption for quick results. The remaining 5% of the market is attributed to alternative formulations such as edibles, sprays, and infused beverages, which are gaining popularity due to their innovative delivery formats and consumer-friendly appeal.
Cbd Oil (Cannabidiol Oil) Market, Segmentation by Product
The Cbd Oil (Cannabidiol Oil) Market has been segmented by Product into Hemp Oil, and Marijuana Oil.
Hemp Oil
Hemp-derived CBD oil dominates the CBD oil market with an estimated 60% share. This product is extracted from industrial hemp plants containing minimal THC, making it legal in a wide range of countries. Its non-psychoactive nature makes it a popular choice in dietary supplements, skincare, and wellness applications. With the growing trend toward plant-based and natural health solutions, hemp oil continues to experience strong consumer demand across health-conscious demographics.
Marijuana Oil
Representing roughly 40% of the market, marijuana-based CBD oil is derived from cannabis varieties rich in THC and CBD. While more tightly regulated, this formulation is increasingly accepted for therapeutic use in managing conditions like chronic pain, neurological disorders, and cancer-related symptoms. As cannabis legislation evolves and medical research supports its efficacy, marijuana oil is gaining traction, particularly in markets with progressive regulatory environments.
Cbd Oil (Cannabidiol Oil) Market, Segmentation by Application
The Cbd Oil (Cannabidiol Oil) Market has been segmented by Application into Pharmaceuticals, Food & Beverages - Gummies, Chewing Gums, Chocolate bars, Candies, Beverages, Dairy Products, Bakery Products, and Snacks, Cosmetics, and Others.
Pharmaceuticals
The pharmaceutical use of CBD oil represents a leading application segment, contributing to approximately 35% of the market. This rise is driven by increasing adoption in prescription medications for conditions such as epilepsy, anxiety, and chronic pain. With expanding clinical research and regulatory support, pharmaceutical-grade CBD oil is gaining credibility and traction in modern healthcare systems worldwide.
Food & Beverages
Comprising close to 30% of the global market, the food and beverage segment is booming with a variety of CBD-infused products, including gummies, chewing gum, chocolate bars, candies, beverages, dairy items, bakery goods, and snacks. Consumers are embracing these offerings for their convenience and potential wellness benefits. The trend toward functional foods and natural health products continues to fuel innovation in this category.
Cosmetics
CBD-based cosmetics hold around 20% of the market, appealing to consumers seeking natural and plant-derived skincare solutions. Known for its anti-inflammatory and antioxidant qualities, CBD is now widely used in serums, creams, balms, and lotions. This segment is benefiting from increasing demand for clean beauty and anti-aging skincare, pushing both mass-market and luxury brands to integrate CBD into their product lines.
Others
Accounting for about 15% of the total market, the ‘Others’ includes uses in pet care, aromatherapy, and wellness supplements. CBD oil is gaining recognition in these areas for its calming and holistic health effects. As awareness grows, this segment is expected to evolve quickly, with innovative products targeting both human and animal wellness.
Cbd Oil (Cannabidiol Oil) Market, Segmentation by Distribution Channel
The Cbd Oil (Cannabidiol Oil) Market has been segmented by Distribution Channel intoDirect/B2B, Indirect/B2C, Hospital Pharmacy, Retail Pharmacy, Hypermarkets/Supermarkets, Convenience Store, Online Retail, and Others.
Direct/B2B and Indirect/B2C
The direct B2B distribution model makes up around 20% of the CBD oil market. This channel is essential for bulk transactions between producers and commercial clients, such as pharmaceutical companies, wellness brands, and personal care manufacturers. Meanwhile, the indirect B2C segment, accounting for 25%, includes retail partnerships and third-party sellers that enable broader market reach. With growing product visibility and consumer education, the B2C pathway continues to expand globally.
Hospital and Retail Pharmacies
Hospital pharmacies contribute nearly 10% of the total distribution, supplying prescription-grade CBD oil to patients under regulated conditions. Retail pharmacies, with a 15% share, offer over-the-counter CBD products that appeal to customers seeking health and wellness solutions. These pharmacies benefit from strong consumer trust, making them a reliable option for therapeutic CBD items.
Hypermarkets/Supermarkets and Convenience Stores
Together, hypermarkets and supermarkets hold about 10% of the CBD oil market. These retail giants provide shelf space to various CBD formats, increasing visibility and encouraging impulse purchases. Convenience stores, which hold approximately 5%, are strategically located to offer quick access to CBD snacks, drinks, and smaller wellness items, contributing to everyday consumer adoption.
Online Retail and Others
The online retail captures about 15% of CBD oil sales. This channel thrives on user-friendly shopping experiences, broad product variety, and discreet delivery. E-commerce platforms have become increasingly popular for CBD shopping as consumers value convenience and privacy. The ‘Others’ category, at 5%, includes boutique shops, wellness clinics, and alternative therapy providers offering curated and often premium CBD product lines.
Cbd Oil (Cannabidiol Oil) Market, Segmentation by Geography
In this report, the Cbd Oil (Cannabidiol Oil) Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Cbd Oil (Cannabidiol Oil) Market Share (%), by Geographical Region
North America
North America holds a commanding 40% share of the CBD oil market. This leadership stems from early legalization efforts in the U.S. and Canada, combined with strong consumer demand and robust product availability. The region also benefits from well-established supply chains, high health awareness, and consistent investment in research and development, positioning it as the global hub for CBD innovation.
Europe
With a market share of approximately 25%, Europe is a prominent player in the CBD oil industry. The continent is experiencing a surge in demand for cannabidiol-based health and wellness products, especially in countries like Germany, the United Kingdom, and the Netherlands. Regulatory clarity for medicinal cannabis and increasing acceptance of alternative treatments are driving this regional growth.
Asia Pacific
Asia Pacific currently accounts for around 15% of the market and shows promising potential. The region is gradually embracing CBD oil, particularly in emerging markets such as Australia, Japan, and Thailand. While regulatory hurdles remain, rising healthcare awareness, a growing middle class, and evolving cannabis laws are paving the way for wider market penetration.
Middle East & Africa and Latin America
Together, Middle East & Africa and Latin America represent about 20% of global CBD oil consumption. Latin America, contributing nearly 12%, benefits from supportive government policies and increasing medical cannabis usage in countries like Colombia, Uruguay, and Brazil. Middle East & Africa, at roughly 8%, is still in the early adoption stage but holds long-term growth potential as public perception and legal frameworks begin to shift.
Cbd Oil (Cannabidiol Oil) Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Cbd Oil (Cannabidiol Oil) Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers:- Rising demand for natural pain relief
- Increasing acceptance of CBD in wellness
-
Growing prevalence of anxiety and sleep disorders - The growing prevalence of anxiety and sleep disorders is a key driver of the CBD oil (cannabidiol oil) market. Increasing stress levels due to modern lifestyles, work-related pressures, and the lingering mental health effects of global events such as the COVID-19 pandemic have led to a surge in individuals seeking natural, non-addictive remedies. CBD oil, known for its potential to promote relaxation, reduce anxiety, and improve sleep quality, is gaining widespread acceptance among consumers looking for alternative therapies.
Unlike traditional pharmaceutical treatments, which often carry the risk of dependency or adverse side effects, CBD oil is perceived as a safer and more holistic option. This growing consumer preference is prompting healthcare practitioners, wellness brands, and retailers to expand their product offerings and invest in further research. As awareness of CBD's therapeutic benefits continues to grow, particularly in mental health management, the market is expected to see sustained demand and diversification across various formulations and delivery methods.
Restraints:
- Lack of Clear Labeling Guidelines
- Potential for Regulatory Crackdowns
-
Product Quality and Consistency Challenges - Product quality and consistency challenges remain a significant restraint in the CBD oil (cannabidiol oil) market. Due to the lack of standardized regulations across regions, there is considerable variability in the purity, potency, and formulation of CBD products. This inconsistency undermines consumer trust and makes it difficult for healthcare providers to confidently recommend CBD oil as a reliable therapeutic option. In some cases, products may contain inaccurate labeling, residual solvents, or even trace amounts of THC beyond legal limits.
Furthermore, the absence of strict quality control measures impacts the ability of manufacturers to ensure uniform efficacy across batches. This has led to concerns regarding the safety, authenticity, and therapeutic reliability of many CBD oil products, especially in unregulated markets. As a result, despite growing interest in CBD for health and wellness, these quality-related challenges are impeding broader adoption and limiting the market’s potential until clearer regulatory frameworks and manufacturing standards are universally implemented.
Opportunities:
- Continued Research on Medical Benefits
- Integration with Traditional Medicine
-
Development of Pharmaceutical-Grade CBD Oil - The development of pharmaceutical-grade CBD oil presents a compelling opportunity in the cannabidiol oil market. As demand for scientifically backed, high-quality wellness products increases, companies are focusing on producing standardized formulations that meet rigorous pharmaceutical criteria. These efforts aim to enhance the therapeutic credibility of CBD oil, allowing it to be more widely accepted within clinical and regulatory frameworks. Pharmaceutical-grade CBD ensures precise dosing, consistent potency, and controlled purity, which are critical for treating conditions such as epilepsy, chronic pain, anxiety, and sleep disorders.
One of the key drivers behind this opportunity is the growing collaboration between CBD manufacturers and healthcare professionals. By integrating CBD into formal medical protocols, there is greater potential for clinical validation and market expansion. This has led to increased investments in clinical trials, quality assurance, and regulatory compliance, which help bridge the gap between consumer wellness trends and established pharmaceutical standards. Such advancements can significantly elevate market trust and foster broader acceptance among both patients and physicians.
Pharmaceutical-grade CBD oil also opens the door for insurance reimbursement and prescription-based distribution, particularly in countries where cannabis-derived medications are tightly regulated. This facilitates access for patients who may not consider over-the-counter CBD products due to concerns about efficacy or safety. Moreover, healthcare systems that adopt these standardized solutions are better equipped to monitor treatment outcomes and ensure safe, evidence-based use of cannabinoids in medical care.
As global regulatory frameworks gradually evolve, the ability to manufacture and distribute CBD oil that complies with pharmaceutical benchmarks is becoming a strategic differentiator. Companies that invest in GMP-certified production, traceable sourcing, and robust R&D pipelines stand to benefit from this transition. Ultimately, the move toward pharmaceutical-grade CBD oil is not only improving the product landscape but also positioning the industry for long-term growth in both therapeutic and wellness applications.
Cbd Oil (Cannabidiol Oil) Market Competitive Landscape Analysis
Key players in Centesis Catheters Market include:
- Charlotte's Web Holdings, Inc.
- Your CBD Store (SUNMED)
- Medterra
- CBD American Shaman
- cbdMD
- NuLeaf Naturals, LLC
- Isodiol International Inc.
- PharmaHemp
- Canopy Growth Corporation
- Aurora Cannabis Inc.
- Elixinol
- Medical Marijuana, Inc.
- Endoca
- Bluebird Botanicals
- Tilray Brands, Inc.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Formulation
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Cbd Oil (Cannabidiol Oil) Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Rising demand for natural pain relief
-
Increasing acceptance of CBD in wellness
-
Growing prevalence of anxiety and sleep disorders
-
- Restraints
-
Lack of Clear Labeling Guidelines
-
Potential for Regulatory Crackdowns
-
Product Quality and Consistency Challenges
-
- Opportunities
- Continued Research on Medical Benefits
- Integration with Traditional Medicine
- Development of Pharmaceutical-Grade CBD Oil
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Cbd Oil (Cannabidiol Oil) Market, By Type, 2021 - 2031 (USD Million)
- THC Dominant
- CBD Dominant
- Marijuana Based
- Hemp Based
- Cbd Oil (Cannabidiol Oil) Market, By Formulation, 2021 - 2031 (USD Million)
- Pills & Capsule
- Creams
- Roll-Ons
- Transdermel Patches
- Drops
- Other
- Cbd Oil (Cannabidiol Oil) Market, By Product, 2021 - 2031 (USD Million)
- Hemp Oil
- Marijuana Oil
- Cbd Oil (Cannabidiol Oil) Market, By Application, 2021 - 2031 (USD Million)
- Pharmaceuticals
- Food & Beverages
- Gummies
- Chewing Gums
- Chocolate bars
- Candies
- Beverages
- Dairy Products
- Bakery Products
- Snacks
- Cosmetics
- Others
- Cbd Oil (Cannabidiol Oil) Market, By Distribution Channel, 2021 - 2031 (USD Million)
-
Direct/B2B
-
Indirect/B2C
-
Hospital Pharmacy
-
Retail Pharmacy
-
Hypermarkets/Supermarkets
-
Convenience Store
-
Online Retail
-
Others
-
- Cbd Oil (Cannabidiol Oil) Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Cbd Oil (Cannabidiol Oil) Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Charlotte's Web Holdings, Inc.
- Your CBD Store (SUNMED)
- Medterra
- CBD American Shaman
- cbdMD
- NuLeaf Naturals, LLC
- Isodiol International Inc.
- PharmaHemp
- Canopy Growth Corporation
- Aurora Cannabis Inc.
- Elixinol
- Medical Marijuana, Inc.
- Endoca
- Bluebird Botanicals
- Tilray Brands, Inc.
- Company Profiles
- Analyst View
- Future Outlook of the Market